Protecting workers and the surrounding environment from exposure to hazardous compounds poses an increasing challenge to pharmaceutical manufacturers as new and more potent active pharmaceutical ingredients (APIs) enter the processing pipeline, such as cytotoxic drugs to treat cancer.
Separation and purification processes potentially expose workers to harmful, biologically active, contaminating particulates and cataylysts filtered from the APIs. To help remedy the problem, Pall is introducing the GBK Containment System which provides the pharmaceutical industry with an all-in-one contained glove bag/housing system for filter change-out.
Biosensis MAP2 antibodies
Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...
Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration
The antibodies are specific to CTC surface markers to enable the sensitive and specific...
Microbiologics UV-BioTAG QC microorganisms for quality control testing
UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...